Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | LTA4H | P09960 | 4/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 6/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 6/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 5/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 5/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.42 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.42 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.37 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL897659 | 0.94 | LTA4H (0.43) | GAALTA4HCYP1A2CYP2D6CYP2C9 | |
| SCHEMBL4276048 | 0.89 | — | — | |
| SCHEMBL387690 | 0.80 | — | — | |
| SCHEMBL6667770 | 0.80 | KDM4E (0.44) | TSHRTDP1 | |
| SCHEMBL6669977 | 0.79 | TSHR (0.37) | GAATSHRL3MBTL1CA2 | |
| SCHEMBL6671624 | 0.79 | LSS (0.46) | CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL6671018 | 0.78 | ALDH1A1 (0.50) | — | |
| SCHEMBL6670235 | 0.78 | ALDH1A1 (0.33) | GAA | |
| SCHEMBL6672655 | 0.77 | KDM4E (0.47) | — | |
| SCHEMBL6667813 | 0.77 | HTT (0.45) | LTA4HCYP1A2CYP2D6CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2790828-B1 | PREPARATION OF AN OLEFIN OLIGOMERIZATION CATALYST | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2018-09-19 | — | — | EP | disclosed |
| US-9956548-B2 | Preparation of an olefin oligomerization catalyst | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2018-05-01 | — | — | US | disclosed |
| CN-104105545-B | preparation of olefin oligomerization catalyst | 切弗朗菲利浦化学公司 | 2017-07-04 | — | — | CN | disclosed |
| EP-2790828-A1 | PREPARATION OF AN OLEFIN OLIGOMERIZATION CATALYST | Chevron Phillips Chemical Company LP (US) | 2014-10-22 | — | — | EP | disclosed |
| CN-104105545-A | Preparation of olefin oligomerization catalyst | CHEVRON PHILLIPS CHEMICAL COMOANY LP | 2014-10-15 | — | — | CN | disclosed |
| WO-2013089962-A1 | PREPARATION OF AN OLEFIN OLIGOMERIZATION CATALYST | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2013-06-20 | — | — | WO | disclosed |
| US-20130150642-A1 | Preparation of an Olefin Oligomerization Catalyst | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2013-06-13 | — | — | US | disclosed |
| US-7605215-B2 | Process for producing olefin copolymerization catalyst and process for producing olefin copolymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-10-20 | — | — | US | disclosed |
| US-20080227937-A1 | Process for Producing Olefin Copolymerization Catalyst and Process for Producing Olefin Copolymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-09-18 | — | — | US | disclosed |
| EP-0424048-A2 | Electrically conductive pigmentary composites | KERR-McGEE CHEMICAL CORPORATION (US) | 1991-04-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130150642-A1 | Preparation of an Olefin Oligomerization Catalyst | PPOX, COASY, COG8 | GAA 3955/4885LTA4H 4169/4885CYP1A2 1031/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.